We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
By MHRA Chief Executive Lawrence Tallon
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to use a randomised controlled trial to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
How investigators and sponsors should manage clinical trials during COVID-19
How to use a crossover randomised controlled trial to evaluate your digital health product.
New analysis of the current clinical trial landscape in the UK shows clear opportunities to shape the future of medical research and patient care.
How to use an N-of-1 study to evaluate your digital health product.
Find out about help you can get moving from benefits to work - training, work trials, starting your own business, help with drug or alcohol problems, carer support
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).